Literature DB >> 20877558

Phenobarbital-induced bullous lesions in a non-comatose patient.

Michael Keng1, Maritza Lagos, Michael R Liepman, Kimberly Trever.   

Abstract

The occurrence of dermatologic bullous lesions is well documented after barbiturate-induced intoxication. However, this rare clinicopathological entity is only reported in the setting of a coma or lethal toxicity. This case report presents a case of a noncomatose, nonimmobilized patient who developed systemic bullous lesions after an acute ingestion of oral phenobarbital. This case illustrates that bullous lesions can occur as a result of nontoxic phenobarbital doses, in the setting of subtherapeutic barbiturate blood levels. All previous case reports suggest phenobarbital produces either systemic bullae only after coma-inducing doses or a localized bullous reaction after a high-dose intravenous injection. This case challenges this previously held association. Although the exact mechanism of the bullous lesions remains unknown, the clinical course of the lesions is self-limiting and does not require additional care beyond the treatment of a superficial burn. Resolution of the bullae occured within two weeks. Since phenobarbital continues to be prescribed orally, physicians should recognize bullous lesions as a potential adverse dermatological reaction from non-lethal oral doses of phenobarbital.

Entities:  

Keywords:  adverse cutaneous drug reactions; barbiturate; blistering drug eruptions; bullous lesions; phenobarbital; phenobarbital toxicity; vesiculobullous drug-induced disorders

Year:  2006        PMID: 20877558      PMCID: PMC2945899     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  11 in total

1.  OCCURRENCE OF BULLOUS LESIONS IN ACUTE BARBITURATE INTOXICATION.

Authors:  G W BEVERIDGE; A A LAWSON
Journal:  Br Med J       Date:  1965-03-27

2.  Localized subepidermal bullae after intravenous phenobarbital.

Authors:  M Haroun; H R Jakubovic; J R Nethercott
Journal:  Cutis       Date:  1987-03

Review 3.  Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.

Authors:  S R Knowles; L E Shapiro; N H Shear
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

4.  Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions.

Authors:  B Rzany; O Correia; J P Kelly; L Naldi; A Auquier; R Stern
Journal:  Lancet       Date:  1999-06-26       Impact factor: 79.321

5.  Skin eruptions in drug-induced coma.

Authors:  N B Pinkus
Journal:  Med J Aust       Date:  1971-10-30       Impact factor: 7.738

6.  Bullous lesions in acute barbiturate poisoning.

Authors:  H Yatzidis
Journal:  JAMA       Date:  1971-07-12       Impact factor: 56.272

7.  Characteristic traumatic skin lesions in drug-induced coma.

Authors:  S Mandy; A B Ackerman
Journal:  JAMA       Date:  1970-07-13       Impact factor: 56.272

8.  Drug-induced sweat gland necrosis in a non-comatose patient: a case presentation.

Authors:  C Ferreli; V I Sulica; N Aste; L Atzori; M Pinna; P Biggio
Journal:  J Eur Acad Dermatol Venereol       Date:  2003-07       Impact factor: 6.166

9.  Coma blisters: report and review.

Authors:  C Dunn; J L Held; J Spitz; D N Silvers; M E Grossman; S R Kohn
Journal:  Cutis       Date:  1990-06

Review 10.  Differential diagnosis of severe cutaneous drug eruptions.

Authors:  Nicolas Bachot; Jean-Claude Roujeau
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.